Menu
10/07/2009
Gene Defect Linked To Allergy, BMJ Finds
Defects in a particular gene - the filaggrin gene - are associated with a significantly increased risk of developing allergic disorders such as eczema, rhinitis, and asthma, concludes a study published on bmj.com today.
Allergic diseases have increased in recent decades and now affect up to one in three children in economically developed countries. For many years researchers have looked for genes that might contribute to allergic diseases but, until recently no major associations had been described, and a real "allergy gene" was elusive.
However, recent reports have consistently pointed to a strong influence of the filaggrin gene in maintaining an effective skin barrier against the environment.
So researchers at the University of Edinburgh analysed the results of 24 studies to investigate if filaggrin gene mutations increase the risk of developing allergic sensitisation and allergic disorders.
Differences in study quality were taken into account to identify and minimise bias.
Pooling the results showed that filaggrin gene mutations significantly increase the risk of developing allergic sensitisation, atopic eczema, allergic rhinitis, and asthma in people with eczema. The relationship between filaggrin gene mutations and atopic eczema was particularly strong.
Filaggrin gene mutations also increased the risk of asthma in people with atopic eczema.
"These findings provide strong supporting evidence that, at least in a subset of those with allergic problems, the filaggrin gene defect may be the fundamental predisposing factor not only for the development of eczema but also for initial sensitisation and progression of allergic disease," said the authors.
"Our finding suggest that filaggrin is a robust biomarker for allergic conditions," they add.
Further studies now need to explore whether filaggrin can be used to identify those at high risk. Restoring skin barrier function in filaggrin deficient people in early life may also help prevent the development of sensitisation and halt the development and progression of allergic disease, they conclude.
This study represents an important breakthrough in understanding the genetic basis of this complex disorder, said experts from Singapore in an accompanying editorial. The next challenge will be to distinguish different genotypes of allergy, which could revolutionise the prevention, diagnosis, and treatment of allergy in children, they conclude.
(JM/BMcc)
Allergic diseases have increased in recent decades and now affect up to one in three children in economically developed countries. For many years researchers have looked for genes that might contribute to allergic diseases but, until recently no major associations had been described, and a real "allergy gene" was elusive.
However, recent reports have consistently pointed to a strong influence of the filaggrin gene in maintaining an effective skin barrier against the environment.
So researchers at the University of Edinburgh analysed the results of 24 studies to investigate if filaggrin gene mutations increase the risk of developing allergic sensitisation and allergic disorders.
Differences in study quality were taken into account to identify and minimise bias.
Pooling the results showed that filaggrin gene mutations significantly increase the risk of developing allergic sensitisation, atopic eczema, allergic rhinitis, and asthma in people with eczema. The relationship between filaggrin gene mutations and atopic eczema was particularly strong.
Filaggrin gene mutations also increased the risk of asthma in people with atopic eczema.
"These findings provide strong supporting evidence that, at least in a subset of those with allergic problems, the filaggrin gene defect may be the fundamental predisposing factor not only for the development of eczema but also for initial sensitisation and progression of allergic disease," said the authors.
"Our finding suggest that filaggrin is a robust biomarker for allergic conditions," they add.
Further studies now need to explore whether filaggrin can be used to identify those at high risk. Restoring skin barrier function in filaggrin deficient people in early life may also help prevent the development of sensitisation and halt the development and progression of allergic disease, they conclude.
This study represents an important breakthrough in understanding the genetic basis of this complex disorder, said experts from Singapore in an accompanying editorial. The next challenge will be to distinguish different genotypes of allergy, which could revolutionise the prevention, diagnosis, and treatment of allergy in children, they conclude.
(JM/BMcc)
Related UK National News Stories
Click here for the latest headlines.
24 June 2003
£50m funding unveiled for NHS gene research
The government is set to promote the development of genetics within the NHS following its decision to plough £50 million into the scheme over the next three years. The White Paper 'Our Inheritance, Our Future - Realising the potential of genetics in the NHS' sets out the government's strategy.
£50m funding unveiled for NHS gene research
The government is set to promote the development of genetics within the NHS following its decision to plough £50 million into the scheme over the next three years. The White Paper 'Our Inheritance, Our Future - Realising the potential of genetics in the NHS' sets out the government's strategy.
25 June 2003
NHS allergy services 'totally inadequate'
Allergy services in the NHS are "totally inadequate" and cannot cope with the rising amount and increasing severity of allergy in the UK, according to a new report from the Royal College of Physicians (RCP).
NHS allergy services 'totally inadequate'
Allergy services in the NHS are "totally inadequate" and cannot cope with the rising amount and increasing severity of allergy in the UK, according to a new report from the Royal College of Physicians (RCP).
02 August 2004
Gene therapy trial for cancer patients gets green light
The green light has been given for a large clinical trial of a new gene therapy treatment for patients with Glioma - one of the most aggressive types of brain tumours for which there is currently no cure. The new gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients.
Gene therapy trial for cancer patients gets green light
The green light has been given for a large clinical trial of a new gene therapy treatment for patients with Glioma - one of the most aggressive types of brain tumours for which there is currently no cure. The new gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients.
12 August 2013
Minister Supports Allergy Treatment Campaign
Jo Swinson, MP for East Dunbartonshire, has pledged her support for a campaign to highlight the availability of emergency treatment in pharmacies. Ms Swinson almost died earlier this year after experiencing a life-threatening allergic reaction.
Minister Supports Allergy Treatment Campaign
Jo Swinson, MP for East Dunbartonshire, has pledged her support for a campaign to highlight the availability of emergency treatment in pharmacies. Ms Swinson almost died earlier this year after experiencing a life-threatening allergic reaction.
20 February 2009
Scientists 'Find Cure' For Deadly Peanut Allergy
A team of British scientists have moved closer to finding a cure for a potentially fatal peanut allergy. A successful trial saw a team from Cambridge's Addenbrooke's hospital give tiny does of peanut flour to children to help them build up a tolerance over a six-month period.
Scientists 'Find Cure' For Deadly Peanut Allergy
A team of British scientists have moved closer to finding a cure for a potentially fatal peanut allergy. A successful trial saw a team from Cambridge's Addenbrooke's hospital give tiny does of peanut flour to children to help them build up a tolerance over a six-month period.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
